<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02851394</url>
  </required_header>
  <id_info>
    <org_study_id>Bethenod Ellouze 2014</org_study_id>
    <nct_id>NCT02851394</nct_id>
  </id_info>
  <brief_title>Advantage of Tramadol in Local Analgesia Post-Sternotomy</brief_title>
  <acronym>ATLAS</acronym>
  <official_title>Evaluation Of The Efficacy Of A Bolus Infiltration Of The Anaesthetic Tramadol Associated With Continuous Local Anaesthesia Administered Via A Wound Catheter Following Heart Surgery Via Sternotomy At Dijon Chu Single-Centre, Double-Blind, Randomized, Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      Sternotomy, the reference approach for heart surgery, may induce profound and intense
      post-operative pain. One method of analgesia used is patient-controlled intravenous morphine.

      The analgesic efficacy of continuous wound infiltration at the sternum following heart
      surgery has been demonstrated.

      The analgesic catheter placed near the sternotomy wound reduces the consumption of morphine.

      The aim of this study is to determine whether a bolus of tramadol associated with the
      continuous administration of levobupivacaine via the wound catheter could potentiate the
      local anaesthetic effects, thus leading to a decreased consumption of postoperative
      intravenous morphine, and a decrease in morphine-related side effects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Consumption of morphine, expressed in milligrams, in the post-operative period</measure>
    <time_frame>48 hour after extubation</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Heart Surgery Via Sternotomy</condition>
  <condition>Post-operative Analgesia</condition>
  <arm_group>
    <arm_group_label>Levobupivacaine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Levobupivacaine + tramadol group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine</intervention_name>
    <arm_group_label>Levobupivacaine group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>levobupivacaine</intervention_name>
    <arm_group_label>Levobupivacaine + tramadol group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tramadol</intervention_name>
    <arm_group_label>Levobupivacaine + tramadol group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Persons who have provided written consent

          -  Patients over 18 years old

          -  Patients undergoing heart surgery via sternotomy: aortic valve surgery, mitral valve
             surgery, tricuspid valve surgery, atrial myxoma, coronary artery bypass graft, aorta
             surgery

          -  Patients undergoing emergency or scheduled surgery

        Exclusion Criteria:

          -  Adults under guardianship

          -  Persons without national health insurance cover

          -  Pregnant or breast-feeding women

          -  Patients already included in the study once

          -  Patients with aortic dissection

          -  Patients with mediastinitis or sternal nonunion

          -  Patients undergoing heart surgery for the second or more time

          -  Patients with local infection or generalized bacteraemia-type infection

          -  Patients with hypersensitivity to local anaesthetics or to tramadol or to opiates or
             to one of the excipients present in the products used

          -  Patients with hypersensitivity to paracetamol or to paracetamol hydrochloride (prodrug
             of paracetamol)

          -  Patients on antidepressants, gabapentin, pregabalin, neuroleptics

          -  Patients with a history of convulsions or epilepsy

          -  Patients with preoperative cognitive dysfunction

          -  Patients with intracranial hypertension

          -  Chronic use of morphines or high-dose steroid or non-steroid anti-inflammatory agents

          -  Patients with acute or chronic kidney failure (creatininemia &gt; 170 µmol/L)

          -  Patients with liver failure or porphyria

          -  Patients under 17 years old

          -  Patients with severe respiratory failure

          -  Patients treated with a non-selective MAOI (iproniazid), a selective MAOI A
             (moclobemid, toloxatone), selective MAO-B inhibitor (Selegiline) or linezolid
             (Zyvoxid®)

          -  Patients with acute intoxication or an overdose of products that depress the central
             nervous system (alcohol, hypnotics, other analgesics…)

          -  Patients with severe hypotension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2016</study_first_submitted>
  <study_first_submitted_qc>July 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2016</study_first_posted>
  <last_update_submitted>October 9, 2017</last_update_submitted>
  <last_update_submitted_qc>October 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tramadol</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

